1. Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
    Fiorella Calabrese et al, 2022, International Journal of Molecular Sciences CrossRef
  2. Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer
    Haeyoung Lee et al, 2021, Annals of Laboratory Medicine CrossRef
  3. A Case of EGFR Mutation-positive Non-small Cell Lung Cancer Diagnosed as Combined Small Cell Lung Cancer in a Surgical Specimen After Osimertinib Treatment
    Eri Iwami et al, 2020, Haigan CrossRef
  4. Treatment of advanced ALK-rearranged NSCLC following second-generation ALKā€“TKI failure
    Akito Fukuda et al, 2023, Expert Review of Anticancer Therapy CrossRef
  5. The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
    Yue Pan et al, 2021, Frontiers in Oncology CrossRef
  6. Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases
    Hao Liu et al, 2022, Frontiers in Oncology CrossRef
  7. Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failure
    Chen Yang et al, 2024, Frontiers in Immunology CrossRef
  8. Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations
    Juanjuan Dong et al, 2021, Cancer Management and Research CrossRef
  9. Small cell lung cancer transformation during antitumor therapies: A systematic review
    Xing Chai et al, 2021, Open Medicine CrossRef
  10. EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
    Zhen Qin et al, 2024, Journal of Experimental Medicine CrossRef
  11. Application Value of Serum TK1 and PCDGF, CYFRA21-1, NSE, and CEA plus Enhanced CT Scan in the Diagnosis of Nonsmall Cell Lung Cancer and Chemotherapy Monitoring
    Xiang He et al, 2022, Journal of Oncology CrossRef